← Research library

Peptide-based Anxiolytics: Molecular Aspects of Heptapeptide Selank Biological Activity

Lab research · 2018

What was studied
Radioligand binding and isolated brain-cell membrane assays
Main finding
The authors examine GABA-binding modulation as a possible mechanistic explanation.

Study data at a glance

Participants or experimental model
Radioligand binding and isolated brain-cell membrane assays
Reported results
The authors examine GABA-binding modulation as a possible mechanistic explanation.
Study limitations and source details

Study limitations

  • Receptor-binding results are laboratory evidence, not proof of clinical efficacy.
  • Interactions in an assay do not establish safe combinations with other drugs.

Source details

Journal publication

Indexed citation and English abstract checked; full methods and risk of bias not appraised.

Sources checked

Citation

In vitroEnglish abstract

Tatiana V Vyunova, Lioudmila Andreeva, Konstantin Shevchenko, Nikolay Myasoedov. Peptide-based Anxiolytics: Molecular Aspects of Heptapeptide Selank Biological Activity Curr Mol Pharmacol. PMID 30255741

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards